8. 5-Catheter/vascular access care observations
Assess staff adherence to aseptic technique when connecting and disconnecting
catheters and during dressing changes .
6-Catheter hub disinfection
Scrub catheter hubs with an appropriate antiseptic after cap is removed and
before accessing.
Perform every time catheter is accessed or disconnected.
12. 8-Chlorhexidine for skin antisepsis
Use an alcohol-based chlorhexidine (>0.5%) solution as the first line skin
antiseptic agent for central line insertion and during dressing changes .
Alternatives for patients with chlorhexidine intolerance:
Povidone-iodine (preferably with alcohol) or 70% alcohol .
13. 9-Antimicrobial ointment for hemodialysis catheter exit site
(after catheter insertion and at each hemodialysis session ) .
Povidone iodine
ointment
or
Bacitracin/gramicidin/polymyxin B ointment
( not available in U.S) .
Bacitracin/neomycin/polymyxin B
(is available )and might have a similar benefit but studies
have not thoroughly evaluated its effect for prevention of
blood stream and exit-site infections .
Other ointment have been studied (Mupirocin)
However, concerns exist about development of antimicrobial resistance and also
their ability to cover the spectrum of potential pathogens (e.g., gram-negative
and gram-positive bacteria) that can cause bloodstream infections in dialysis
patients.
18. Do not administer systemic antimicrobial prophylaxis routinely before insertion
or during use of an intravascular catheter to prevent catheter colonization or
CRBSI . (Category IB )
Use prophylactic antimicrobial lock solution in patients with long term catheters
who have a history of multiple CRBSI despite optimal maximal adherence to
aseptic technique . (Category II )
23. -Definition 1-Hyperemia, induration, and/or tenderness ≤2 cm
from catheter exit site.
2-May be associated with fever and purulent
drainage from the exit site .
3-It may or may not be associated with bacteremia
-If there is purulent
drainage
It should be collected and sent for Gram staining
and culture before antibiotic administration .
Draw blood sample for blood culture
-The patient should be
investigated for nasal
carriage of
Staphylococcus
If present, treated with
intranasal mupirocin
cream
Twice a day to each
nostril for 5 days
24. Empiric antibiotic
-Exit site
without fever
-Topical antibiotic +/ - systemic antibiotic
-Modify the antibiotic regimen once culture and sensitivity result available
-Duration 7 to 14 days
Depending on the microorganism isolated .
27. Definition 1-Tenderness, hyperemia, and/or induration that extends
>2 cm from the exit site and along the subcutaneous
tunnel.
2-It may or may not be associated with bacteremia .
If there is
purulent
drainage
It should be collected and sent for Gram staining and
culture before antibiotic administration .
Draw blood sample for blood culture
28. Empiric Treatment
Start broad spectrum empiric antibiotics to cover both gram-positive and
negative organisms .
Modify antibiotic regimen when culture and sensitivity results are available.
Duration In the absence of a concurrent CRBSI
Are typically treated for 10 to 14 days
Depending on the microorganism isolated and local practice.
Duration If a CRBSI is also present
The duration of therapy will be as CRBSI
30. 3- a h t r r l t d
l o s r a
i f c io
(CRBSI )
31.
32. RISK FACTORS
History of previous
catheter-related
Bacteremia,
Recent surgery,
Dabetes mellitus,
Iron overload,
Immunosuppression,
Hypoalbuminemia
COMPLICATIONS
Metastatic complications
as osteomyelitis,
Endocarditis,
Septic arthritis,
or epidural abscess.
33. 1-Suspect CRSBI in patient with
-Fever and/or chills
-Hemodynamic instability, altered mental status, and other symptoms
and/or signs of sepsis , such as hypothermia, acidosis, and hypotension
Not related to another infection site .
34. 2- Paired Blood Culture ( prior to antibiotic initiation )
therapy )
1- Peripheral + central from catheter hub ( if catheter retained )
2-Centeral from the catheter + dialysis circuit ( from hemodialysis line )
in case of peripheral vein absent
3- Peripheral + catheter tip if catheter removed ( distal 5 cm from tip )
35. Consideration for blood sample
1-Obtain samples for blood culture prior to the initiation of antibiotic therapy
2-Marke the bottles to reflect the site from which the samples were obtained
(catheter and peripheral vein ) .
3- For percutaneously drawn blood samples
Skin preparation with use of alcohol or alcoholic chlorhexidine( 10.5%)
(allow adequate skin contact and drying times to mitigate blood culture
contamination )
4-Peripheral blood samples should be from vessels that are not intended for
future use in creating a dialysis fistula (e.g., hand veins)
5-If a blood sample is obtained through a catheter
Clean the catheter hub with either alcohol or tincture of iodine or alcoholic
chlorhexidine (10.5%)
6-The volume of the locking solution should be removed prior to blood culture
collection .
36. 3-Empiric antimicrobial therapy for hemodialysis catheter related
blood stream infection
CRBSI result from a broad array of Gram positive and Gram
negative organism
Gram +ve microorganisms -Staphylococcus aureus ( MSSA or
MRSA)
-Enetrococci
- Coagulase negative Staphylococci
Gram -ve bacilli -Pseudomonas species and others
Fungi -Candida species
Polymicrobial --------------------------------------------------
Others --------------------------------------------------
37. -Choice of antimicrobial agent for CRBSI based on coverage of
Gram +ve bactria + Gram -ve bactria +/- fungal infection
M.O Antimicrobial agent
For Gram
+ve M.O
- Cefazolin ( MSSA )
- Vancomycin or teicoplanin (MRSA )
For Gram
-ve M.O
- 3rd generation cephalosporin :Ceftazidim
- 4th generation cephalosporin :Cefepime
- Beta lactam / Beta lactamase inhibitor :Piperacillin /Tazobactam
- Carbapenem : (Imipenem / cilastatin )-Meropenem
Fungal
infection
Fluconazole
( if risk for C.glabarata – C .Krusei is low )
(If no previous exposure in the last 3 months )
Amphotericin
Indication for
fungal
infection
Septic patient with following risk factor
1- Prolonged use of broad spectrum antibiotic
2-Femoral catheter
3- Hematological malignancy
4-Bone marrow or organ transplant
5-TPN
6-Colonization of candida at multiple site
38. -Fever
-Chills
-Hemodynamic instability
-Or altered mental status
Resolve within 2-3 days and there is no metatstatic infection or
exit siteinfection or tunnel infection .
The catheter can be retained,
and an antibiotic lock can be
used as adjunctive therapy
after each dialysis session for
10–14 days
The infected catheter can
be exchanged over a
guidewire for a new,
longterm hemodialysis
catheter
39. Definitive diagnosis of dialysis catheter-induced bacteremia requires
one of
-Concurrent positive blood cultures of the same organism from the catheter and a
peripheral vein.
-Culture of the same organism from both the catheter tip and at least one
percutaneous blood culture .
CRSBI diagnosis unlikely
Both sets of initial blood cultures have negative results
If there is no other identified source of infection and signs and symptoms of
bacteremia have resolved Stopping empiric therapy
40. 1-De- escalation to single antibiotic once culture available.
2-Patients who receive empirical vancomycin or
teicoplanin and who are found to have CRBSI due to
methicillin-susceptible S. aureus should be switched to
cefazolin .
3-Patients who have CRBSI due to vancomycin- resistant
enterococci can be treated with oral linezolid .
41. If peripheral blood culture –ve and catheter culture +ve
Antibiotic are not generaly recommended
The exception is patients whose catheter tips grow S.
aureus and have negative blood culture
These patients should receive 5–7 days of antibiotic
44. A-Placement of a temporary non-tunneled catheter is typically
the best alternative option for short-term dialysis
access.
B- A temporary non tunneled catheter should be inserted into another
anatomical site .
C- If absolutely no alternative sites are available for catheter insertion, then
exchange the infected catheter over a guide
wire.
D-After a hemodialysis catheter is removed for CRBSI, a long-term
hemodialysis catheter can be placed once blood cultures with negative results
are obtained.
45. Table 1 :Treatment duration for CRBSI
Gram –ve bacilli 10 – 14 days
Coagulase -ve
Staphylococcus
species
Catheter is remove
Treat wih antibiotic for 5-7 days
Catheter retained
Treat for 10 -14 day
Enterococcus Catheter retained (Treat with antibiotic for 7-10) days
Staphylococcus
auerus
1-Antibiotic for 4-6 weeks unless patient have exception
recommended in 2
2- Short duration of antimicroibial ( minimum 14 days)
If patient
-Not diabetic
-Not immune suppressed
( not receiving systemic steroid or other immune suppressive
drugs , and is non neutropenic)
-If catheter removed,
-If patient has no prosthetic intravascular device (e.g pacemaker
or recently placed vascular graft )
-If fever and bacteremia resolve within 72 hr after initiation of
antimicrobial therapy
46. Table 1 :Treatment duration for CRBSI
-Candida SPP 14 days after 1st –ve blood culture
-Endocarditis 4–6-week
-Septic thrombophlebitis 4–6-week
-Osteomyelitis 6–8 weeks of therapy
47. (ALT) involves instillation of a highly concentrated antibiotic solution
into an intravascular catheter lumen
For CRBSI, antibiotic lock should not be used alone; instead, it should be used in
conjunction with systemic antimicrobial therapy .
Antibiotic lock is indicated for patients with CRBSI involving long-term catheters with
no signs of exit site or tunnel infection for whom catheter salvage is the goal .
The antibiotic/heparin lock solution is prepared immediately before instillation
into the catheter lumen .
The antibiotic lock should be replaced every 48 hours, after each HD session .
This mixture of antibiotic and anticoagulant is then instilled ("locked") into
each catheter lumen at the end of each dialysis session, in place of standard
heparin locks, for the duration of the systemic antibiotic ( 10- 14 days ).
48. Table 1:Antibiotic lock therapy ( ALT ) preparation
Antibiotic and dosage Heparin or saline, IU/mL
Vancomycin, 2.5 mg/ ml 2500 or 5000
Vancomycin, 2.0 mg/mL 10
Vancomycin, 5.0 mg/mL 0 or 5000
Ceftazidime, 0.5 mg/mL 100
Cefazolin, 5.0 mg/mL 2500 or 5000
Ciprofloxacin, 0.2 mg/mL 5000
Gentamicin, 1.0 mg/mL 2500
Ampicillin 10.0 mg/mL 10 or 5000
1- These antibiotic lock solutions will not precipitate at the given concentrations.
2-A precipitate appears when mixing a 10 mg/mL of vancomycin with 10,000
IU/mL of heparin; however, by agitating the solution for 10 s, the precipitation
resolves and the solution remains precipitate-free for72 h at 37C
3-A Vancomycin at 5 mg/mL is more efficacious than at 1 mg/mL in eradicating
staphylococci embedded within biofilm .
50. 1-Blood culture :Obtain blood cultures from catheter and peripheral vein or
bloodline if peripheral vein not feasible
2- Empiric antibiotic
Blood
culture
-ve
Stop
ABX
Resolution of bactremia and fungemia in 2-3 days and
fever
Presistant
bacteremia /
fungmia and
fever
Coagulase
–ve
Staphylococci
Gram
–ve
bacilli
S.aureus
Candida
albican Remove
CVC
Retain CVC
Antibiotic
for 10 -14
day
,Continue
ABL
Or
guidewire
exchange
Retain
CVC
Antibiotic
for 10 -14
day
,Continue
ABL
Or
guidewire
exchange
Remove
CVC
And
Antibiotic
x 3 weeks
If TEE
–ve
Guidewire
CVC
exchange
Antifungal
for 14 day
after 1st
-ve blood
culture
Antibiotic
x4-6 and
look of
metastatic
Infection
51. Antibiotic Dose
Cefazolin 20 mg/kg (actual body weight),
rounded to the nearest 500-mg increment,
after dialysis
Ceftazidim 500 mg to 1gm q 24 hr or 1- 2 gm q 48 – 72 hr
after dialysis
Cefepime 1 gm on day 1 then 0.5 -1 gm q 24 hr or 1-2 gm q 48 -
72 ( after dialysis )
Piperacillin/ Tazobactam 2.25 gm q 12 hr after hemodialysis session
Vancomycin 20 mg/ kg loading dose infused during last hr of
Dialysis session
Then 500 mg during the last 30 min of the following
dialysis session
Meropenem 500 mg every 24 hr after hemodialysis
Assume 3 times weekly and complete IHD sessions
Imipenem / Cilastatin 250 mg to 500 mg q 12 hr after hemodialysis session
Linezolide 600 mg every 12 hr after hemodialysis
52. Antifungal Dose
Fluconazole iv 100 – 200 q 24 hr
Or 200 – 400 q 48 – 72 hr
Amphotericin B
Caspofungin 70 mg iv loading dose followed by 50 mg iv
daily
Micafungin 100 mg iv daily
53. References
1. Mermel LA, Allon M, Bouza E, et al. Clinical practice guidelines for the
diagnosis and management of intravascular catheter-related infection
update by the infectious disease society of america. Clin Infec Dis.( 2009 )
. 2-CDC Guidelines for the Prevention of Intravascular Catheter-Related Infections.
( 2011 )
3-UpToDate (Dialysis catheter infection )
4- NKF KDOQI Vascular access guideline. ( 2006 )
5- Diagnosis, prevention and treatment of haemodialysis catheter-related
bloodstream infections (CRBSI): a position statement of European
Renal Best Practice (ERBP) NDT Plus (2010)
6-Canadian Journal of Kidney Healthand DiseaseVolume 3: 1–11 ( 2016 )
7 - Hand book of dialysis 5th edition
8-Johns Hoppikens antimicrobial guidline (2015 – 2016 )
